id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1992-N-0049-0002,FDA,FDA-1992-N-0049,Topical Drug Products Containing Benzoyl Peroxide; Required Labeling; Extension of Comment Period,Notice,NEC-Notice of Extension,1995-06-07T04:00:00Z,1995,6,1995-06-07T04:00:00Z,1995-07-18T03:59:59Z,2010-02-25T18:34:06Z,,0,0,090000648052bd0a
FDA-1992-N-0049-0001,FDA,FDA-1992-N-0049,Topical Drug Products Containing Benzoyl Peroxide; Required Labeling,Proposed Rule,NPR-Notice of Proposed Rule-Making,1995-02-23T05:00:00Z,1995,2,1995-02-23T05:00:00Z,1995-05-19T03:59:59Z,2010-02-25T18:30:48Z,,0,0,090000648052bcf4
FDA-1992-N-0049-0022,FDA,FDA-1992-N-0049,Reference 13 - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling]   - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling],Supporting & Related Material,BKG-Background Material,1995-02-17T05:00:00Z,1995,2,,,2010-02-25T21:11:46Z,,0,0,090000648052bd26
FDA-1992-N-0049-0004,FDA,FDA-1992-N-0049,Background Material,Supporting & Related Material,BKG-Background Material,1995-02-17T05:00:00Z,1995,2,,,2008-05-16T23:34:17Z,,0,0,090000648052bd0e
FDA-1992-N-0049-0009,FDA,FDA-1992-N-0049,"Reference 2 - ""Kurokawa, et al., Studies on the Promoting and Complete Carcinogenic Activities of Some Oxidizing Chemicals in Skin Carcinogensis"" - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling]",Supporting & Related Material,BKG-Background Material,1995-02-17T05:00:00Z,1995,2,,,2010-02-25T20:47:08Z,,0,0,090000648052bd19
FDA-1992-N-0049-0010,FDA,FDA-1992-N-0049,Reference 3 - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling],Supporting & Related Material,BKG-Background Material,1995-02-17T05:00:00Z,1995,2,,,2010-02-25T21:06:34Z,,0,0,090000648052bd1a
FDA-1992-N-0049-0008,FDA,FDA-1992-N-0049,"Reference 1 - ""Slaga, et al., Skin Tumor-Promoting Activity of Benzoyl Peroxide, a Widely Used Free Radical-Generating Compound"" - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling]",Supporting & Related Material,BKG-Background Material,1995-02-17T05:00:00Z,1995,2,,,2010-02-25T20:42:29Z,,0,0,090000648052bd18
FDA-1992-N-0049-0007,FDA,FDA-1992-N-0049,"FDA Memorandum to Dockets Management Branch, February 22, 1995, Public Administrative File for Proposal Rule - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling]",Supporting & Related Material,BKG-Background Material,1995-02-17T05:00:00Z,1995,2,,,2010-02-25T20:36:08Z,,0,0,090000648052bd17
FDA-1992-N-0049-0018,FDA,FDA-1992-N-0049,Background Material,Supporting & Related Material,BKG-Background Material,1995-02-17T05:00:00Z,1995,2,,,2008-05-16T23:34:17Z,,0,0,090000648052bd22
FDA-1992-N-0049-0013,FDA,FDA-1992-N-0049,"Reference 1.2 - ""Correspondence and Memoranda"" - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling]",Supporting & Related Material,BKG-Background Material,1995-02-17T05:00:00Z,1995,2,,,2010-02-25T20:55:48Z,,0,0,090000648052bd1d
FDA-1992-N-0049-0017,FDA,FDA-1992-N-0049,Background Material,Supporting & Related Material,BKG-Background Material,1995-02-17T05:00:00Z,1995,2,,,2008-05-16T23:34:17Z,,0,0,090000648052bd21
FDA-1992-N-0049-0005,FDA,FDA-1992-N-0049,"Reference 10 - ""Iversen, Carcinogenesis Studies with Benzoyl- Peroxide"" - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling]",Supporting & Related Material,BKG-Background Material,1995-02-17T05:00:00Z,1995,2,,,2010-02-25T20:13:37Z,,0,0,090000648052bd12
FDA-1992-N-0049-0012,FDA,FDA-1992-N-0049,"Reference 17 - ""Physicians' Desk Reference, 47th Edition"" - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling]",Supporting & Related Material,BKG-Background Material,1995-02-17T05:00:00Z,1995,2,,,2010-02-25T20:53:18Z,,0,0,090000648052bd1c
FDA-1992-N-0049-0015,FDA,FDA-1992-N-0049,Background Material,Supporting & Related Material,BKG-Background Material,1995-02-17T05:00:00Z,1995,2,,,2008-05-16T23:34:17Z,,0,0,090000648052bd1f
FDA-1992-N-0049-0011,FDA,FDA-1992-N-0049,"Reference 16 - ""Hogan, et al., Studies on the Promoting and Complete Carcinogenic Activities of Some Oxidizing Chemicals in Skin Carcinogensis"" - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling]",Supporting & Related Material,BKG-Background Material,1995-02-17T05:00:00Z,1995,2,,,2010-02-25T20:51:17Z,,0,0,090000648052bd1b
FDA-1992-N-0049-0003,FDA,FDA-1992-N-0049,Background Material,Supporting & Related Material,BKG-Background Material,1995-02-17T05:00:00Z,1995,2,,,2008-05-16T23:34:17Z,,0,0,090000648052bd0c
FDA-1992-N-0049-0016,FDA,FDA-1992-N-0049,Background Material,Supporting & Related Material,BKG-Background Material,1995-02-17T05:00:00Z,1995,2,,,2008-05-16T23:34:17Z,,0,0,090000648052bd20
FDA-1992-N-0049-0014,FDA,FDA-1992-N-0049,"Reference 7 - ""Comments C31, PR1, & PR2"" - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling]",Supporting & Related Material,BKG-Background Material,1995-02-17T05:00:00Z,1995,2,,,2010-02-25T20:59:44Z,,0,0,090000648052bd1e
FDA-1992-N-0049-0020,FDA,FDA-1992-N-0049,Background Material,Supporting & Related Material,BKG-Background Material,1995-02-17T05:00:00Z,1995,2,,,2008-05-16T23:34:17Z,,0,0,090000648052bd24
FDA-1992-N-0049-0021,FDA,FDA-1992-N-0049,Background Material,Supporting & Related Material,BKG-Background Material,1995-02-17T05:00:00Z,1995,2,,,2008-05-16T23:34:17Z,,0,0,090000648052bd25
FDA-1992-N-0049-0019,FDA,FDA-1992-N-0049,Background Material,Supporting & Related Material,BKG-Background Material,1995-02-17T05:00:00Z,1995,2,,,2008-05-16T23:34:17Z,,0,0,090000648052bd23
FDA-1992-N-0049-0006,FDA,FDA-1992-N-0049,"Reference 11 - ""Iversen, Skin Tumorigenesis and Carcinogenesis Studies With7,12-Dimethylbenz[a]anthracene, Ultraviolet Light, Benzoyl Peroxide (Panoxyl gel 5%) and Ointment Gel "" - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling]",Supporting & Related Material,BKG-Background Material,1995-02-17T05:00:00Z,1995,2,,,2010-02-25T20:24:04Z,,0,0,090000648052bd14